| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 79651 |
六酯基-O6-冠[3]芳烃[3]四嗪,Hexester-O6-corona[3]arene[3]tetrazine（ |
111 |
WYQ |
2024-11-29 |
| 79652 |
3，6-二甲基-六氢-s-四嗪,也可称为3，6-二甲基-1，4-二氢-S-四嗪 |
120 |
WYQ |
2024-11-29 |
| 79653 |
3，6-二（对氯苄基）-s-四嗪 |
86 |
WYQ |
2024-11-29 |
| 79654 |
3，6-二（对氯苯基）-s-四嗪 |
88 |
WYQ |
2024-11-29 |
| 79655 |
1,2,4,5-四嗪-3,5-双(1H-1,2,4-三唑-3-硝氨基)含能离子盐 |
104 |
WYQ |
2024-11-29 |
| 79656 |
三环化合物1,4-二氢-1,2,4,5-四嗪-3,5-双(1H-1,2,4-三唑-3-氨基) |
170 |
WYQ |
2024-11-29 |
| 79657 |
四嗪基团封端的四臂聚乙二醇（Tz-PEG） |
125 |
WYQ |
2024-11-29 |
| 79658 |
Azido-mono-amide-DOTA ，叠氮基-单-酰胺-DOTA |
89 |
wyh |
2024-11-29 |
| 79659 |
Iron DOTA Sodium Salt, 5 mg 铁DOTA钠盐 |
89 |
zcy |
2024-11-29 |
| 79660 |
DOTA-TATE ， DOTA-3-酪氨酰基-奥曲肽 , 177943-89-4 |
165 |
wyh |
2024-11-29 |
| 79661 |
2570254-31-6，Pomalidomide-C3-I |
80 |
kx |
2024-11-29 |
| 79662 |
1262403-91-7 , 七肽DOTA-YLYEIAR |
97 |
wyh |
2024-11-29 |
| 79663 |
DOTA-amide dihydrate；DOTA酰胺二水合物 |
97 |
zcy |
2024-11-29 |
| 79664 |
RGD,[18F]FB-c(RGDyK) , N-4-[18F]Fluorobenzoyl-c(RGDyK |
106 |
wyh |
2024-11-29 |
| 79665 |
1262403-90-6 , 七肽DOTA-VLASSAR |
89 |
wyh |
2024-11-29 |
| 79666 |
486429-99-6，(S)-C3-TunePhos |
90 |
kx |
2024-11-29 |
| 79667 |
海藻酸钠-聚乙二醇-大环配体 ；alginate-PEG-DOTAM |
125 |
wyh |
2024-11-29 |
| 79668 |
DOTA-三叔丁酯-叠氮 ；DOTA-(COOt-Bu)3-azide |
137 |
wyh |
2024-11-29 |
| 79669 |
DOTA-五聚乙二醇-C4-二苯并环辛炔 DOTA-PEG5-C4-DBCO |
106 |
zcy |
2024-11-29 |
| 79670 |
1539292-60-8，APN-C3-NH-Boc |
104 |
kx |
2024-11-29 |
| 79671 |
DOTA-cyclo(Arg-Gly-Asp-DPhe-Lys) |
95 |
wyh |
2024-11-29 |
| 79672 |
DOTA-TMTP1的性质与应用 |
84 |
wyh |
2024-11-29 |
| 79673 |
DOTA-三聚乙二醇-叠氮(盐酸盐) DOTA-PEG3-azide(HCl) 1428146-79-5 |
86 |
zcy |
2024-11-29 |
| 79674 |
7-R-7-磷杂降冰片二烯M(CO)5(M=Mo,W)配合物 |
170 |
h |
2024-11-29 |
| 79675 |
DOTA-cyclo(RGDfK) ；DOTA-RGD |
130 |
wyh |
2024-11-29 |
| 79676 |
2376146-48-2，ZN-c3 |
97 |
kx |
2024-11-29 |
| 79677 |
Mem-Tz-Rh 四嗪与罗丹明结构连接溶酶体靶向探针 |
143 |
WYQ |
2024-11-29 |
| 79678 |
Mito-Tz-BDP Bodipy与四嗪共轭连接线粒体靶向探针 |
191 |
WYQ |
2024-11-29 |
| 79679 |
3-三氟甲基-6-硝基胍基[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪化合物 |
115 |
WYQ |
2024-11-29 |
| 79680 |
DOTA-「Tyr3」-Octreotide , DOTA-(酪氨酸3)-奥曲肽 |
76 |
wyh |
2024-11-29 |
| 79681 |
1,4-二吡唑基-2,3,5,6-四嗪构筑的金属有机框架 |
120 |
WYQ |
2024-11-29 |
| 79682 |
1,4-二-(吡唑基)-2,3,5,6-四嗪修饰三氟甲基磺酸锌[Zn(bptz)2]n |
165 |
WYQ |
2024-11-29 |
| 79683 |
3,6-二(4-吡啶基)-1,2,4,5-四嗪 |
83 |
WYQ |
2024-11-29 |
| 79684 |
DOTA-PEG4-MeTz DOTA-PEG4-甲基四嗪 甲基四嗪聚乙二醇大环化合物 |
135 |
zcy |
2024-11-29 |
| 79685 |
5966-29-0；N-棕榈酰-D-赤型-鞘氨醇；C16 Dihydroceramide (d18:0/16:0) |
312 |
kx |
2024-11-29 |
| 79686 |
p-SCN-Bn-DOTA ；2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
81 |
wyh |
2024-11-29 |
| 79687 |
DOTA-Suc-Lys-(FAPI-04)2 3029114-60-8 DOTA-琥珀酰基-赖氨酸-(FAPI-04)2 |
98 |
zcy |
2024-11-29 |
| 79688 |
913528-04-8 , DOTAM-mono-acid-CSDN |
62 |
wyh |
2024-11-29 |
| 79689 |
降冰片烯单体[5-降冰片烯-2-亚甲氧基-4-己氧基联苯(PhHN)] |
140 |
h |
2024-11-29 |
| 79690 |
Tm-DOTA , DOTA大环化合物 |
79 |
wyh |
2024-11-29 |
| 79691 |
四嗪基UIO-66金属有机骨架 |
247 |
WYQ |
2024-11-29 |
| 79692 |
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) 定制 |
102 |
zcy |
2024-11-29 |
| 79693 |
四嗪功能基团修饰寡聚(p-苯撑乙炔)分子 |
128 |
WYQ |
2024-11-29 |
| 79694 |
icariside C3，CAS号：108906-48-5 |
139 |
zyl |
2024-11-29 |
| 79695 |
1,2,4,5-四嗪-3,5-双(1H-1,2,4-三唑-3-硝胺基) |
115 |
WYQ |
2024-11-29 |
齐岳微信公众号
官方微信
库存查询